Product Information
ERYTHROMYCIN 0.5% EYE OINTMENT is a generic product labeled by Fera Pharmaceuticals, LLC, priced at $7.2287 per GM under NDC 48102005711. Its NADAC has been published 77 times since Apr 17, 2024.
Strength
5 mg/g
Manufacturer
Fera Pharmaceuticals, LLCNDC
48102005711
Classification
Generic
Dosage Form
OINTMENT
Route
OPHTHALMIC
Effective Date
9/17/2025
Active Ingredients
ERYTHROMYCINApproval Type
UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
On Market Since
9/27/2023
Pharmacological Classes
Price Statistics
The NADAC for ERYTHROMYCIN 0.5% EYE OINTMENT has been published 77 times since Apr 17, 2024, and over the history we have for it it has risen 100.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $7.2287 per GM |
|---|---|
| All-time high | $7.6426 (Sep 10, 2025) |
| All-time low | $3.4370 (May 22, 2024) |
| Median price | $3.8307 |
| Average price | $5.0465 |
| Largest weekly change | +23.4% (Jan 22, 2025) |
| Weeks tracked | 77 |
| Tracking since | Apr 17, 2024 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+100.8%
Last surveyed Oct 1, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 61% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Fera Pharmaceuticals, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Erythromycin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Macrolide Antimicrobial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ERYTHROMYCIN 0.5% EYE OINTMENT?
The current National Average Drug Acquisition Cost (NADAC) for ERYTHROMYCIN 0.5% EYE OINTMENT, manufactured by Fera Pharmaceuticals, LLC, is $7.2287 per GM (NDC 48102005711), effective Oct 1, 2025.
How has the price of ERYTHROMYCIN 0.5% EYE OINTMENT changed over time?
Over the history we have for it, the NADAC for ERYTHROMYCIN 0.5% EYE OINTMENT has risen 100.8%. It has been tracked across 77 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for ERYTHROMYCIN 0.5% EYE OINTMENT?
Since Apr 17, 2024, the NADAC for ERYTHROMYCIN 0.5% EYE OINTMENT has ranged from a low of $3.4370 (May 22, 2024) to a high of $7.6426 (Sep 10, 2025), with a median of $3.8307 per GM.
Are there cheaper alternatives to ERYTHROMYCIN 0.5% EYE OINTMENT?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ERYTHROMYCIN 0.5% EYE OINTMENT, is $2.8266 per GM — about 61% below ERYTHROMYCIN 0.5% EYE OINTMENT.
Who manufactures ERYTHROMYCIN 0.5% EYE OINTMENT?
ERYTHROMYCIN 0.5% EYE OINTMENT (NDC 48102005711) is labeled by Fera Pharmaceuticals, LLC, and CMS classifies it as a generic product.